Loading…
Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases
Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin...
Saved in:
Published in: | FEBS letters 2023-06, Vol.597 (11), p.1489-1502 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133 |
---|---|
cites | cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133 |
container_end_page | 1502 |
container_issue | 11 |
container_start_page | 1489 |
container_title | FEBS letters |
container_volume | 597 |
creator | Kellett, Katherine A. B. Fisher, Kate Aldworth, Harry Hooper, Nigel M. |
description | Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function.
The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes. |
doi_str_mv | 10.1002/1873-3468.14667 |
format | article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10953048</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2820025396</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</originalsourceid><addsrcrecordid>eNqFkc1O3DAUha2qqAy06-6Ql90E_Bc7WaGCoCCBYEHXluPcdFxl4mB7iqJu-gh9xj4JDgMjumJl3-tzvnutg9BnSg4pIeyIVooXXMjqkAop1Tu02HbeowUhVBSlqvku2ovxJ8l1ResPaJcrxkvF5AL9vg0-ge-n6CL2HU5LwL1_-PfnbwtDdGnCvRv9OIvcgANYGJMPON-XMJrk7ZQg4uxdQetMghY3Ez65vqW4WSc8-DTXPlMDNjEZm41PMBMhfkQ7nekjfHo-99H387O704vi6ubb5enXq8IKQVXBupJaIktFKW9t_oJh1pLc6KpWWeCEt6KxHVFtxYysSiHq1hrGGwtWSsr5PjrecMd1k9e0MKRgej0GtzJh0t44_f_L4Jb6h_-lKalLTkSVCV-eCcHfryEmvXLRQt-bAfw6alaxnEbJa5mlRxupDT7GAN12DiV6zkzPCek5If2UWXYcvF5vq38JKQvkRvDgepje4unzsxO2IT8CWHKk9w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2820025396</pqid></control><display><type>article</type><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</creator><creatorcontrib>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</creatorcontrib><description>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function.
The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</description><identifier>ISSN: 0014-5793</identifier><identifier>EISSN: 1873-3468</identifier><identifier>DOI: 10.1002/1873-3468.14667</identifier><identifier>PMID: 37235726</identifier><language>eng</language><publisher>England: John Wiley and Sons Inc</publisher><subject>Animals ; astacin ; BMP1 ; Bone Morphogenetic Protein 1 - metabolism ; Cholesterol ; hepatocytes ; Hepatocytes - metabolism ; Humans ; LDL receptor ; LDL‐cholesterol ; Ligands ; Lipoproteins, LDL - metabolism ; Liver ; Mammals - metabolism ; meprin ; Metabolism ; Mice ; Peptide Hydrolases - metabolism ; protease ; Proteolysis ; Receptors, LDL - genetics ; Receptors, LDL - metabolism ; Sterols</subject><ispartof>FEBS letters, 2023-06, Vol.597 (11), p.1489-1502</ispartof><rights>2023 The Authors. published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><rights>2023 The Authors. FEBS Letters published by John Wiley & Sons Ltd on behalf of Federation of European Biochemical Societies.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</citedby><cites>FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</cites><orcidid>0000-0002-5811-3484</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,776,780,881,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37235726$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kellett, Katherine A. B.</creatorcontrib><creatorcontrib>Fisher, Kate</creatorcontrib><creatorcontrib>Aldworth, Harry</creatorcontrib><creatorcontrib>Hooper, Nigel M.</creatorcontrib><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><title>FEBS letters</title><addtitle>FEBS Lett</addtitle><description>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function.
The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</description><subject>Animals</subject><subject>astacin</subject><subject>BMP1</subject><subject>Bone Morphogenetic Protein 1 - metabolism</subject><subject>Cholesterol</subject><subject>hepatocytes</subject><subject>Hepatocytes - metabolism</subject><subject>Humans</subject><subject>LDL receptor</subject><subject>LDL‐cholesterol</subject><subject>Ligands</subject><subject>Lipoproteins, LDL - metabolism</subject><subject>Liver</subject><subject>Mammals - metabolism</subject><subject>meprin</subject><subject>Metabolism</subject><subject>Mice</subject><subject>Peptide Hydrolases - metabolism</subject><subject>protease</subject><subject>Proteolysis</subject><subject>Receptors, LDL - genetics</subject><subject>Receptors, LDL - metabolism</subject><subject>Sterols</subject><issn>0014-5793</issn><issn>1873-3468</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><recordid>eNqFkc1O3DAUha2qqAy06-6Ql90E_Bc7WaGCoCCBYEHXluPcdFxl4mB7iqJu-gh9xj4JDgMjumJl3-tzvnutg9BnSg4pIeyIVooXXMjqkAop1Tu02HbeowUhVBSlqvku2ovxJ8l1ResPaJcrxkvF5AL9vg0-ge-n6CL2HU5LwL1_-PfnbwtDdGnCvRv9OIvcgANYGJMPON-XMJrk7ZQg4uxdQetMghY3Ez65vqW4WSc8-DTXPlMDNjEZm41PMBMhfkQ7nekjfHo-99H387O704vi6ubb5enXq8IKQVXBupJaIktFKW9t_oJh1pLc6KpWWeCEt6KxHVFtxYysSiHq1hrGGwtWSsr5PjrecMd1k9e0MKRgej0GtzJh0t44_f_L4Jb6h_-lKalLTkSVCV-eCcHfryEmvXLRQt-bAfw6alaxnEbJa5mlRxupDT7GAN12DiV6zkzPCek5If2UWXYcvF5vq38JKQvkRvDgepje4unzsxO2IT8CWHKk9w</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Kellett, Katherine A. B.</creator><creator>Fisher, Kate</creator><creator>Aldworth, Harry</creator><creator>Hooper, Nigel M.</creator><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5811-3484</orcidid></search><sort><creationdate>202306</creationdate><title>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</title><author>Kellett, Katherine A. B. ; Fisher, Kate ; Aldworth, Harry ; Hooper, Nigel M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Animals</topic><topic>astacin</topic><topic>BMP1</topic><topic>Bone Morphogenetic Protein 1 - metabolism</topic><topic>Cholesterol</topic><topic>hepatocytes</topic><topic>Hepatocytes - metabolism</topic><topic>Humans</topic><topic>LDL receptor</topic><topic>LDL‐cholesterol</topic><topic>Ligands</topic><topic>Lipoproteins, LDL - metabolism</topic><topic>Liver</topic><topic>Mammals - metabolism</topic><topic>meprin</topic><topic>Metabolism</topic><topic>Mice</topic><topic>Peptide Hydrolases - metabolism</topic><topic>protease</topic><topic>Proteolysis</topic><topic>Receptors, LDL - genetics</topic><topic>Receptors, LDL - metabolism</topic><topic>Sterols</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kellett, Katherine A. B.</creatorcontrib><creatorcontrib>Fisher, Kate</creatorcontrib><creatorcontrib>Aldworth, Harry</creatorcontrib><creatorcontrib>Hooper, Nigel M.</creatorcontrib><collection>Wiley-Blackwell Open Access Collection</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>FEBS letters</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kellett, Katherine A. B.</au><au>Fisher, Kate</au><au>Aldworth, Harry</au><au>Hooper, Nigel M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases</atitle><jtitle>FEBS letters</jtitle><addtitle>FEBS Lett</addtitle><date>2023-06</date><risdate>2023</risdate><volume>597</volume><issue>11</issue><spage>1489</spage><epage>1502</epage><pages>1489-1502</pages><issn>0014-5793</issn><eissn>1873-3468</eissn><abstract>Bone morphogenetic protein 1 (BMP1), a member of the astacin family of zinc‐metalloproteases, proteolytically cleaves the low‐density lipoprotein receptor (LDLR) within its ligand‐binding domain, reducing the binding and cellular uptake of LDL‐cholesterol. Here, we aimed to determine whether astacin proteases other than BMP1 may also cleave LDLR. Although human hepatocytes express all six astacin proteases, including the meprins and mammalian tolloid, we found through pharmacological inhibition and genetic knockdown that only BMP1 contributed to the cleavage of LDLR in its ligand‐binding domain. We also found that the minimum amino acid change required to render mouse LDLR susceptible to cleavage by BMP1 is mutation at the P1′ and P2 positions of the cleavage site. When expressed in cells, the resulting humanised‐mouse LDLR internalised LDL‐cholesterol. This work provides insight into the biological mechanisms regulating LDLR function.
The low‐density lipoprotein receptor (LDLR) binds LDL‐cholesterol at the cell surface and internalises. The protease BMP1 cleaves LDLR in its ligand‐binding domain, preventing the binding and internalisation of LDL‐cholesterol. BMP1 is a member of the astacin family of zinc metalloproteases, however, no other astacin protease, including the meprins, is involved in cleaving LDLR in human hepatocytes.</abstract><cop>England</cop><pub>John Wiley and Sons Inc</pub><pmid>37235726</pmid><doi>10.1002/1873-3468.14667</doi><tpages>1502</tpages><orcidid>https://orcid.org/0000-0002-5811-3484</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0014-5793 |
ispartof | FEBS letters, 2023-06, Vol.597 (11), p.1489-1502 |
issn | 0014-5793 1873-3468 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10953048 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Animals astacin BMP1 Bone Morphogenetic Protein 1 - metabolism Cholesterol hepatocytes Hepatocytes - metabolism Humans LDL receptor LDL‐cholesterol Ligands Lipoproteins, LDL - metabolism Liver Mammals - metabolism meprin Metabolism Mice Peptide Hydrolases - metabolism protease Proteolysis Receptors, LDL - genetics Receptors, LDL - metabolism Sterols |
title | Proteolysis of the low‐density lipoprotein receptor in hepatocytes is mediated by BMP1 but not by other astacin proteases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-22T18%3A31%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Proteolysis%20of%20the%20low%E2%80%90density%20lipoprotein%20receptor%20in%20hepatocytes%20is%20mediated%20by%20BMP1%20but%20not%20by%20other%20astacin%20proteases&rft.jtitle=FEBS%20letters&rft.au=Kellett,%20Katherine%20A.%20B.&rft.date=2023-06&rft.volume=597&rft.issue=11&rft.spage=1489&rft.epage=1502&rft.pages=1489-1502&rft.issn=0014-5793&rft.eissn=1873-3468&rft_id=info:doi/10.1002/1873-3468.14667&rft_dat=%3Cproquest_pubme%3E2820025396%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c4417-2f51c0657113dc018a2cc0065f8d7ce303d4bcf07d82a685449dca23bcec66133%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2820025396&rft_id=info:pmid/37235726&rfr_iscdi=true |